WallStreetZenWallStreetZen

NASDAQ: RZLT
Rezolute Inc Stock Forecast, Predictions & Price Target

Analyst price target for RZLT

Based on 4 analysts offering 12 month price targets for Rezolute Inc.
Min Forecast
$7.00+165.15%
Avg Forecast
$9.75+269.32%
Max Forecast
$14.00+430.3%

Should I buy or sell RZLT stock?

Based on 4 analysts offering ratings for Rezolute Inc.
Strong Buy
Strong Buy
2 analysts 50%
Buy
2 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their RZLT stock forecasts and price targets.

RZLT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-05-16
lockedlocked$00.00+00.00%2024-04-19
lockedlocked$00.00+00.00%2024-04-18
lockedlocked$00.00+00.00%2024-04-09

1 of 1

Forecast return on equity

Is RZLT forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
34.27%

Forecast return on assets

Is RZLT forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

RZLT revenue forecast

What is RZLT's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$3.7M
Avg 2 year Forecast
$49.9M
Avg 3 year Forecast
$239.8M

RZLT vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
RZLT$2.64$9.75+269.32%Strong Buy
EPRX$2.94N/AN/A
BYSI$2.68N/AN/A
PMVP$2.10$5.75+173.81%Strong Buy
ELTX$10.05$10.00-0.50%Buy

Rezolute Stock Forecast FAQ

Is Rezolute Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: RZLT) stock is to Strong Buy RZLT stock.

Out of 4 analysts, 2 (50%) are recommending RZLT as a Strong Buy, 2 (50%) are recommending RZLT as a Buy, 0 (0%) are recommending RZLT as a Hold, 0 (0%) are recommending RZLT as a Sell, and 0 (0%) are recommending RZLT as a Strong Sell.

If you're new to stock investing, here's how to buy Rezolute stock.

What is RZLT's revenue growth forecast for 2026-2028?

(NASDAQ: RZLT) Rezolute's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.22%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.95%.

Rezolute's revenue in 2024 is $0.On average, 2 Wall Street analysts forecast RZLT's revenue for 2026 to be $147,697,341, with the lowest RZLT revenue forecast at $124,418,956, and the highest RZLT revenue forecast at $170,975,726. On average, 2 Wall Street analysts forecast RZLT's revenue for 2027 to be $2,001,339,105, with the lowest RZLT revenue forecast at $982,508,399, and the highest RZLT revenue forecast at $3,020,169,812.

In 2028, RZLT is forecast to generate $9,626,214,332 in revenue, with the lowest revenue forecast at $6,940,570,971 and the highest revenue forecast at $12,311,857,694.

What is RZLT's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: RZLT) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is RZLT's Price Target?

According to 4 Wall Street analysts that have issued a 1 year RZLT price target, the average RZLT price target is $9.75, with the highest RZLT stock price forecast at $14.00 and the lowest RZLT stock price forecast at $7.00.

On average, Wall Street analysts predict that Rezolute's share price could reach $9.75 by May 16, 2025. The average Rezolute stock price prediction forecasts a potential upside of 269.32% from the current RZLT share price of $2.64.

What is RZLT's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: RZLT) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.